Perrigo Co. Reaches New 12-Month High at $158.15 (PRGO)
Perrigo (NASDAQ:PRGO) set a new 52-week high on Wednesday, Stock Ratings Network.com reports. The company traded as high as $158.15 and last traded at $158.11, with a volume of 988,859 shares. The stock had previously closed at $154.58.
A number of research firms have recently commented on PRGO. Analysts at Bank of America Corp. upgraded shares of Perrigo from a “neutral” rating to a “buy” rating in a research note to investors on Tuesday. They now have a $171.00 price target on the stock, up previously from $162.00. Separately, analysts at RBC Capital initiated coverage on shares of Perrigo in a research note to investors on Monday. They set a “top pick” rating and a $187.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Perrigo in a research note to investors on Friday, January 3rd. They now have a $161.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $151.04.
Perrigo has a one year low of $98.79 and a one year high of $157.47. The stock has a 50-day moving average of $153.7 and a 200-day moving average of $134.2. The company has a market cap of $14.902 billion and a price-to-earnings ratio of 32.61.
Perrigo (NASDAQ:PRGO) last announced its earnings results on Thursday, October 31st. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.12. The company had revenue of $933.00 million for the quarter, compared to the consensus estimate of $900.10 million. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company’s revenue for the quarter was up 21.3% on a year-over-year basis. On average, analysts predict that Perrigo will post $6.62 earnings per share for the current fiscal year.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.